查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591730

医疗设备的软体市场:现状分析与预测(2024年～2032年)

Software as a Medical Device Market: Current Analysis and Forecast (2024-2032)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 150 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计预测期内（2024-2032 年），医疗设备软体 (SaMD) 市场将实现约 10.71% 的显着成长。随着全球慢性病的盛行率和发生率逐年上升，迫切需要扩大SaMD等创新医疗解决方案的应用，以应对日益增长的疾病族群。 SaMD 将促进早期诊断并加强疾病监测过程，进一步协助医疗专业人员提供适当的疾病管理。例如，根据世界卫生组织（WHO）的数据，每年约有4,100万人死于慢性疾病。高血压、肥胖和高血糖等代谢危险因子是这一重点族群的主要死亡原因。为了应对日益增多的慢性病，​​世卫组织还建议注重预防措施，如早期发现、及时筛检和有效的治疗措施。

SaMD 具有提供准确、快速诊断的潜力，这是高效疾病管理过程的关键要素。这导致患者和医疗保健提供者对 SaMD 解决方案的需求不断增加，从而带动软体即医疗设备市场显着增长。

根据部署，市场分为云端和本地。其中，基于云端的服务由于其成本效益、高效的资料储存容量以及可透过网路连接从任何地方存取的能力而占据了很大的市场占有率。

根据应用，市场分为诊断、监测和临床管理。其中，疾病控制在全球范围内占有很大占有率。推动成长的因素包括人口老化以及糖尿病、心血管疾病和癌症等慢性病盛行率的增加。 SaMD 在快速、高品质资料收集和改善医疗服务方面具有巨大潜力，从而增加了对用于疾病临床管理的软体即医疗设备解决方案的需求。

依治疗领域，市场分为代谢、肿瘤学、呼吸学、心臟科、神经科学、血液学等。其中，肿瘤学领域的复合年增长率最高，这得益于癌症发病率的上升以及人们对癌症管理计划中早期诊断重要性的认识的不断提高。

为了更了解软体作为医疗设备的市场采用情况，我们根据北美（美国、加拿大和北美其他地区）、欧洲（德国、法国、英国、西班牙、义大利和欧洲其他地区）、亚太地区（中国、日本、印度和亚太其他地区）和世界其他地区的全球影响力对市场进行了分析。北美占据了软体医疗器材市场的大部分占有率，预计在预测期内将保持稳定的成长率。北美拥有强大的医疗保健基础设施和采用新技术的能力，这带动了 SaMD 市场的强劲投资和创新。此外，该地区也是 Imagen Technologies, Inc. 和 Digital Diagnostics Inc. 等主要製造商的所在地。鑑于巨大的生产量和对医疗保健解决方案的高需求，预计该地区将在预测期内主导医疗设备软体市场的需求。

市场的主要参与者包括Siemens Healthineers, GE HealthCare Technologies Inc.，Koninklijke Philips N.V.，Aptar Digital Health，Qure.ai Technologies Private Limited，Imagen Technologies, Inc.，Digital Diagnostics Inc.，Viz.ai，HeartFlow, Inc.，Hologic, Inc.等。

目录

第1章 市场简介

  • 市场定义
  • 主要目的
  • 相关利益者
  • 限制事项

第2章 调查手法或前提条件

  • 调查流程
  • 调查手法
  • 受访者简介

第3章 摘要整理

  • 产业摘要
  • 各市场区隔预测
    • 市场成长的强度
  • 地区展望

第4章 市场动态

  • 促进因素
  • 机会
  • 阻碍因素
  • 趋势
  • PESTEL分析
  • 需求面分析
  • 供给面分析
    • 合併和收购
    • 投资Scenario

第5章 全球医疗设备的软体市场收益 , 2022-2032年

第6章 市场洞察:各部署

  • 云端
  • 内部部署

第7章 市场洞察:各用途

  • 诊断
  • 监测
  • 临床管理

第8章 市场洞察:各治疗领域

  • 代谢
  • 肿瘤
  • 呼吸系统
  • 心臟血管
  • 神经科
  • 血液
  • 其他

第9章 市场洞察:各地区

  • 北美
    • 美国
    • 加拿大
    • 其他北美地区
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 全球其他地区

第10章 价值链分析

  • 主要零组件分析
  • 市场参与企业一览

第11章 竞争情形

  • 竞争仪表板
  • 竞争市场定位分析
  • 波特的五力分析

第12章 企业简介

  • Siemens Healthineers
    • Company Overview
    • Key Financials
    • SWOT Analysis
    • Product Portfolio
    • Recent Developments
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips N.V.
  • Aptar Digital Health Inc.
  • Qure.ai Technologies Private Limited
  • Imagen Technologies, Inc.
  • Digital Diagnostics Inc.
  • Viz.ai
  • HeartFlow, Inc.
  • Hologic, Inc.

第13章 缩写与前提条件

第14章 附录

简介目录
Product Code: UMHE213044

Software as a Medical Device (SaMD) refers to software designed for one or more medical purposes to operate independently, without being a part of any hardware medical device. SaMD applications include diagnosis, monitoring or management of health conditions. It operates on general-purpose computing platforms, which means it does not need to be integrated into a physical medical device to fulfill its medical role. It can run on various platforms, such as mobile applications and cloud-based systems, that further enhance accessibility and usability in healthcare settings.

The Software as a Medical Device Market is expected to grow at a significant rate of around 10.71% during the forecast period (2024-2032). With the increasing global prevalence and incidence of chronic diseases year by year, there is a huge need to increase the application of innovative medical solutions such as SaMD to cater to the need of this growing diseased population. SaMD facilitates early diagnosis and enhances disease monitoring process, which further assists the healthcare professionals in providing appropriate disease management. For instance, as per the World Health Organization (WHO), around 41 million people die each year due to chronic diseases. Metabolic risk factors such as increased blood pressure, obesity and hyperglycemia are the leading cause of death among this major population. To combat the growing chronic diseases, WHO has also suggested emphasis on preventive measures such as early detection, timely screening and effective treatment measures.

SaMD has the potential to provide accurate and rapid diagnosis, which is an important factor for efficient disease management process. This has increased the demand for SaMD solutions among healthcare providers as well as patients, leading to the tremendous growth of the software as a medical device market.

Based on deployment, the market is segmented into cloud and on-premises. Of these, cloud segment holds the major market share due to its cost-effectiveness, efficient data storage capacity and provision of accessibility from any location with internet facility.

Based on the application, the market is segmented into diagnostics, monitoring and clinical management. Of these, disease management has held the major market share across the globe. Some of the factors that have attributed to growth are growing aging population and increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases and cancer. SaMD has huge potential in providing rapid and quality data collection and improved healthcare delivery services, leading to higher demand for software as a medical device solution for the clinical management of the diseases.

Based on therapeutic area, the market is segmented into metabolic, oncology, respiratory, cardiovascular, neuroscience, hematology and others. Of these, the oncology segment has exhibited the highest CAGR, fueled by growing incidence of cancer and increased awareness regarding importance of early diagnosis in the cancer management plan.

For a better understanding of the market adoption of the software as a medical device, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America holds a significant share of the software as a medical device market and is anticipated to maintain a steady growth rate over the forecast period. North America, with a robust healthcare infrastructure, allows adoption of new technologies that leads to substantial investments and innovation in the SaMD market. Additionally, the region is home to some of the largest manufacturers, such as Imagen Technologies, Inc. and Digital Diagnostics Inc. Considering the vast volume of production, and the high demand for healthcare solutions, the region is further anticipated to dominate the demand for software as a medical device market in the forecast period.

Some of the major players operating in the market include Siemens Healthineers, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Aptar Digital Health, Qure.ai Technologies Private Limited, Imagen Technologies, Inc., Digital Diagnostics Inc., Viz.ai, HeartFlow, Inc., Hologic, Inc.

TABLE OF CONTENTS

1.MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Software as a Medical Device Market
  • 2.2. Research Methodology of the Software as a Medical Device Market
  • 2.3. Respondent Profile

3.EXECUTIVE SUMMARY

  • 3.1. Industry Synopsis
  • 3.2. Segmental Outlook
    • 3.2.1. Market Growth Intensity
  • 3.3. Regional Outlook

4.MARKET DYNAMICS

  • 4.1. Drivers
  • 4.2. Opportunity
  • 4.3. Restraints
  • 4.4. Trends
  • 4.5. PESTEL Analysis
  • 4.6. Demand Side Analysis
  • 4.7. Supply Side Analysis
    • 4.7.1. Merger & Acquisition
    • 4.7.2. Investment Scenario

5.GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET REVENUE (USD MN), 2022-2032F

6.MARKET INSIGHTS BY DEPLOYMENT

  • 6.1. Cloud
  • 6.2. On-premises

7.MARKET INSIGHTS BY APPLICATION

  • 7.1. Diagnostics
  • 7.2. Monitoring
  • 7.3. Clinical Management

8.MARKET INSIGHTS BY THERAPEUTIC AREA

  • 8.1. Metabolic
  • 8.2. Oncology
  • 8.3. Respiratory
  • 8.4. Cardiovascular
  • 8.5. Neuroscience
  • 8.6. Hematology
  • 8.7. Others

9.MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10.VALUE CHAIN ANALYSIS

  • 10.1. Key Component Analysis
  • 10.2. List of Market Participants

11.COMPETITIVE LANDSCAPE

  • 11.1. Competition Dashboard
  • 11.2. Competitor Market Positioning Analysis
  • 11.3. Porter Five Forces Analysis

12.COMPANY PROFILED

  • 12.1. Siemens Healthineers
    • 12.1.1. Company Overview
    • 12.1.2. Key Financials
    • 12.1.3. SWOT Analysis
    • 12.1.4. Product Portfolio
    • 12.1.5. Recent Developments
  • 12.2. GE HealthCare Technologies Inc.
  • 12.3. Koninklijke Philips N.V.
  • 12.4. Aptar Digital Health Inc.
  • 12.5. Qure.ai Technologies Private Limited
  • 12.6. Imagen Technologies, Inc.
  • 12.7. Digital Diagnostics Inc.
  • 12.8. Viz.ai
  • 12.9. HeartFlow, Inc.
  • 12.10. Hologic, Inc.

13.ACRONYMS & ASSUMPTION

14.ANNEXURE